Lv3
310 积分 2026-08-11 加入
A novel oral interleukin-23 receptor antagonist peptide, icotrokinra, for moderate-to- severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials
2天前
已完结
Integrating Multimodal AI with Encoded Medicinal Knowledge and Physics Simulations: A Unified Platform for Accelerated Drug Discovery from Patent Analysis to Potency Validation
2天前
已完结
mRNA display: from basic principles to macrocycle drug discovery
3天前
已完结
Ras trafficking, localization and compartmentalized signalling
4天前
已完结
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR
5天前
已完结
Potent side-chain to side-chain cyclized dermorphin analogues containing a carbonyl bridge
8天前
已完结
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure- Based Design
10天前
已完结
Computational Platforms for Membrane-Active Peptide Therapeutic Design
10天前
已完结
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
12天前
已完结
mRNA Display Reaches for the Clinic with New PCSK9 Inhibitor
12天前
已完结
皖公网安备34019202002308
